Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
TAFA5,Chemokine-like protein TAFA-5,Chapter I Certain infectious and parasitic diseases,Candidiasis,Inverse variance weighted,15,0.91 [0.78-1.05],0.179103032508312
TAFA5,Chemokine-like protein TAFA-5,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,Inverse variance weighted,15,0.99 [0.94-1.05],0.801731813184481
TAFA5,Chemokine-like protein TAFA-5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,Inverse variance weighted,15,1.00 [0.96-1.05],0.868012029337001
TAFA5,Chemokine-like protein TAFA-5,Chapter I Certain infectious and parasitic diseases,Mycoses,Inverse variance weighted,15,0.95 [0.85-1.06],0.364978068346102
TAFA5,Chemokine-like protein TAFA-5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,15,1.04 [0.97-1.11],0.234932439941956
TAFA5,Chemokine-like protein TAFA-5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,15,0.60 [0.34-1.06],0.0775632886669522
TAFA5,Chemokine-like protein TAFA-5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,15,1.02 [0.94-1.11],0.642799171993564
TAFA5,Chemokine-like protein TAFA-5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,Inverse variance weighted,15,0.97 [0.87-1.09],0.628906102229003
TAFA5,Chemokine-like protein TAFA-5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,15,2.33 [0.96-5.67],0.062359593620796
TAFA5,Chemokine-like protein TAFA-5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",Inverse variance weighted,15,0.93 [0.82-1.05],0.220499611256008
TAFA5,Chemokine-like protein TAFA-5,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,Inverse variance weighted,15,1.06 [0.95-1.18],0.29534014878339
TAFA5,Chemokine-like protein TAFA-5,Chapter X Diseases of the respiratory system,Later onset COPD,Inverse variance weighted,15,1.04 [0.94-1.14],0.437273249089809
TAFA5,Chemokine-like protein TAFA-5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,Inverse variance weighted,15,1.02 [0.68-1.55],0.912645304199764
TAFA5,Chemokine-like protein TAFA-5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,15,0.99 [0.90-1.08],0.795994516061171
TAFA5,Chemokine-like protein TAFA-5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,15,0.93 [0.84-1.03],0.175057597494973
TAFA5,Chemokine-like protein TAFA-5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,Inverse variance weighted,15,0.96 [0.82-1.11],0.563635690971467
TAFA5,Chemokine-like protein TAFA-5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",Inverse variance weighted,15,1.04 [0.82-1.32],0.746422357682023
TAFA5,Chemokine-like protein TAFA-5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",Inverse variance weighted,15,0.98 [0.83-1.17],0.8596818222351
TAFA5,Chemokine-like protein TAFA-5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,Inverse variance weighted,15,1.06 [0.88-1.27],0.536052631393954
TAFA5,Chemokine-like protein TAFA-5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,15,0.79 [0.51-1.25],0.315670792485646
TAFA5,Chemokine-like protein TAFA-5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,Inverse variance weighted,15,1.04 [0.84-1.30],0.713509376406301
TAFA5,Chemokine-like protein TAFA-5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,Inverse variance weighted,15,0.79 [0.61-1.03],0.0782073325037235
TAFA5,Chemokine-like protein TAFA-5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,Inverse variance weighted,15,0.96 [0.79-1.18],0.726118323704407
TAFA5,Chemokine-like protein TAFA-5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,Inverse variance weighted,15,1.05 [0.98-1.13],0.18531481062138
TAFA5,Chemokine-like protein TAFA-5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,15,1.04 [0.95-1.15],0.38510322675728
TAFA5,Chemokine-like protein TAFA-5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,15,1.05 [0.83-1.32],0.706496958460908
TAFA5,Chemokine-like protein TAFA-5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,15,1.24 [0.97-1.57],0.0810997181134479
TAFA5,Chemokine-like protein TAFA-5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",Inverse variance weighted,15,0.98 [0.90-1.06],0.561561638148434
TAFA5,Chemokine-like protein TAFA-5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,Inverse variance weighted,15,1.13 [1.00-1.27],0.0590592732331545
TAFA5,Chemokine-like protein TAFA-5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,Inverse variance weighted,15,1.06 [0.93-1.20],0.405487553492971
TAFA5,Chemokine-like protein TAFA-5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,15,1.02 [0.97-1.09],0.415817097395967
TAFA5,Chemokine-like protein TAFA-5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,15,1.02 [0.97-1.06],0.4736643716312
TAFA5,Chemokine-like protein TAFA-5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,Inverse variance weighted,15,0.92 [0.76-1.12],0.408393467473035
TAFA5,Chemokine-like protein TAFA-5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,Inverse variance weighted,15,1.09 [0.97-1.23],0.141110020643787
TAFA5,Chemokine-like protein TAFA-5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,Inverse variance weighted,15,1.10 [1.00-1.21],0.043290891578004
TAFA5,Chemokine-like protein TAFA-5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,15,1.00 [0.84-1.19],0.999415263269464
TAFA5,Chemokine-like protein TAFA-5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,Inverse variance weighted,15,1.01 [0.95-1.08],0.717085754436817
TAFA5,Chemokine-like protein TAFA-5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,Inverse variance weighted,15,1.01 [0.96-1.05],0.827793438173402
TAFA5,Chemokine-like protein TAFA-5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,Inverse variance weighted,15,1.01 [0.97-1.04],0.755770600667543
TAFA5,Chemokine-like protein TAFA-5,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",Inverse variance weighted,15,0.91 [0.78-1.06],0.225558819878694
TAFA5,Chemokine-like protein TAFA-5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",Inverse variance weighted,15,0.97 [0.83-1.15],0.74847687582582
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,15,1.02 [0.95-1.09],0.654454791237823
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,Angina pectoris,Inverse variance weighted,15,0.99 [0.92-1.06],0.687412519252998
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,Inverse variance weighted,15,0.90 [0.64-1.26],0.542579111289694
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,Inverse variance weighted,15,1.14 [0.96-1.37],0.133529880468858
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",Inverse variance weighted,15,0.94 [0.87-1.01],0.0991302539886632
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,Cardiac arrest,Inverse variance weighted,15,1.07 [0.88-1.30],0.511546905602174
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",Inverse variance weighted,15,1.14 [0.90-1.46],0.282181252124207
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,Inverse variance weighted,15,1.03 [0.95-1.11],0.502706952295315
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,Conduction disorders,Inverse variance weighted,15,0.98 [0.89-1.08],0.737484612592363
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,Inverse variance weighted,15,1.01 [0.95-1.08],0.685019832402542
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,15,1.04 [0.97-1.11],0.241206784166732
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,15,0.99 [0.85-1.15],0.908483326226462
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,15,1.01 [0.95-1.07],0.720073736647673
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,15,1.01 [0.96-1.07],0.634316085135598
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,15,0.75 [0.37-1.51],0.417961666321146
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",Inverse variance weighted,15,1.00 [0.94-1.06],0.953437649563258
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,15,0.96 [0.89-1.03],0.244094477543273
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,Left bundle-branch block,Inverse variance weighted,15,0.90 [0.73-1.11],0.338364767524233
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",Inverse variance weighted,15,1.03 [0.95-1.12],0.424059134013649
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,15,1.21 [0.96-1.53],0.109189851866199
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,15,0.81 [0.61-1.07],0.129860805347772
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,Inverse variance weighted,15,1.09 [0.74-1.61],0.670741282278584
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,15,1.15 [0.87-1.52],0.329158114897112
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,Inverse variance weighted,15,1.08 [0.99-1.18],0.0898684911479876
TAFA5,Chemokine-like protein TAFA-5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,Inverse variance weighted,15,1.05 [0.98-1.12],0.186383687960324
TAFA5,Chemokine-like protein TAFA-5,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),Inverse variance weighted,15,1.04 [0.91-1.18],0.57587158393548
TAFA5,Chemokine-like protein TAFA-5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,15,1.05 [0.89-1.23],0.552895905873654
TAFA5,Chemokine-like protein TAFA-5,Chapter X Diseases of the respiratory system,Emphysema,Inverse variance weighted,15,1.08 [0.87-1.33],0.499741788754202
TAFA5,Chemokine-like protein TAFA-5,Chapter X Diseases of the respiratory system,All influenza,Inverse variance weighted,15,1.10 [0.99-1.22],0.0669715620659394
TAFA5,Chemokine-like protein TAFA-5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,15,1.03 [0.99-1.08],0.105192771475149
TAFA5,Chemokine-like protein TAFA-5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,15,1.01 [0.97-1.05],0.651927458817304
TAFA5,Chemokine-like protein TAFA-5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,15,0.98 [0.90-1.08],0.737166965144129
TAFA5,Chemokine-like protein TAFA-5,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,15,1.00 [0.93-1.08],0.968404487622453
TAFA5,Chemokine-like protein TAFA-5,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,15,0.97 [0.81-1.16],0.723272559887142
TAFA5,Chemokine-like protein TAFA-5,Chapter X Diseases of the respiratory system,Pulmonary oedema,Inverse variance weighted,15,0.60 [0.39-0.91],0.0157986999947026
TAFA5,Chemokine-like protein TAFA-5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,Inverse variance weighted,15,1.04 [0.98-1.11],0.201539711810042
TAFA5,Chemokine-like protein TAFA-5,Chapter XI Diseases of the digestive system,Cholelithiasis,Inverse variance weighted,15,1.00 [0.93-1.07],0.950913502132388
TAFA5,Chemokine-like protein TAFA-5,Chapter XI Diseases of the digestive system,Constipation,Inverse variance weighted,15,0.96 [0.91-1.01],0.139244295382091
TAFA5,Chemokine-like protein TAFA-5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,Inverse variance weighted,15,1.04 [0.96-1.13],0.361049881753928
TAFA5,Chemokine-like protein TAFA-5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,Inverse variance weighted,15,0.94 [0.86-1.02],0.151064530904011
TAFA5,Chemokine-like protein TAFA-5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,Inverse variance weighted,15,1.01 [0.92-1.11],0.816769577524745
TAFA5,Chemokine-like protein TAFA-5,Chapter XI Diseases of the digestive system,Other diseases of intestines,Inverse variance weighted,15,0.98 [0.94-1.03],0.431565249258234
TAFA5,Chemokine-like protein TAFA-5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",Inverse variance weighted,15,0.95 [0.89-1.01],0.125672131491146
TAFA5,Chemokine-like protein TAFA-5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,Inverse variance weighted,15,1.02 [0.92-1.12],0.732448720744578
TAFA5,Chemokine-like protein TAFA-5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,Inverse variance weighted,15,1.02 [0.78-1.32],0.910079314716793
TAFA5,Chemokine-like protein TAFA-5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,Inverse variance weighted,15,1.06 [0.94-1.19],0.351627276960029
TAFA5,Chemokine-like protein TAFA-5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,Inverse variance weighted,15,0.96 [0.89-1.03],0.233034196685785
TAFA5,Chemokine-like protein TAFA-5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),Inverse variance weighted,15,1.01 [0.89-1.15],0.891489307335473
TAFA5,Chemokine-like protein TAFA-5,Chapter XI Diseases of the digestive system,Acute peritonitis,Inverse variance weighted,15,0.95 [0.77-1.18],0.655461829363224
TAFA5,Chemokine-like protein TAFA-5,Chapter V Mental and behavioural disorders,Any mental disorder,Inverse variance weighted,15,1.03 [1.00-1.07],0.0670647044782759
TAFA5,Chemokine-like protein TAFA-5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",Inverse variance weighted,15,1.10 [1.03-1.17],0.005843635979125
TAFA5,Chemokine-like protein TAFA-5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,Inverse variance weighted,15,1.03 [0.92-1.15],0.587074981798977
TAFA5,Chemokine-like protein TAFA-5,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,Inverse variance weighted,15,0.98 [0.74-1.30],0.909736576159673
TAFA5,Chemokine-like protein TAFA-5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,Inverse variance weighted,15,1.04 [0.97-1.11],0.259474350423031
TAFA5,Chemokine-like protein TAFA-5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,Inverse variance weighted,15,0.97 [0.91-1.03],0.325184648820683
TAFA5,Chemokine-like protein TAFA-5,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",Inverse variance weighted,15,0.97 [0.83-1.12],0.658203454540873
TAFA5,Chemokine-like protein TAFA-5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,Inverse variance weighted,15,1.02 [0.96-1.07],0.571897032481451
TAFA5,Chemokine-like protein TAFA-5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,Inverse variance weighted,15,1.05 [0.98-1.12],0.17459678665212
TAFA5,Chemokine-like protein TAFA-5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,Inverse variance weighted,15,1.03 [0.95-1.12],0.472084998719861
TAFA5,Chemokine-like protein TAFA-5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,15,0.97 [0.82-1.13],0.66767645921483
TAFA5,Chemokine-like protein TAFA-5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,Inverse variance weighted,15,1.02 [0.95-1.09],0.591644743285223
TAFA5,Chemokine-like protein TAFA-5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,Inverse variance weighted,15,1.01 [0.94-1.09],0.792131568184956
TAFA5,Chemokine-like protein TAFA-5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,15,1.03 [0.93-1.14],0.585748630249081
TAFA5,Chemokine-like protein TAFA-5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,Inverse variance weighted,15,1.04 [0.74-1.48],0.817911874632631
TAFA5,Chemokine-like protein TAFA-5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",Inverse variance weighted,15,1.04 [0.99-1.10],0.152376469630925
TAFA5,Chemokine-like protein TAFA-5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,Inverse variance weighted,15,1.07 [1.00-1.14],0.0643896442129264
TAFA5,Chemokine-like protein TAFA-5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,15,1.04 [0.92-1.17],0.564200762663845
TAFA5,Chemokine-like protein TAFA-5,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,Inverse variance weighted,15,0.94 [0.72-1.24],0.670611731419221
TAFA5,Chemokine-like protein TAFA-5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,15,1.01 [0.88-1.17],0.849371630019218
TAFA5,Chemokine-like protein TAFA-5,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,Inverse variance weighted,15,0.96 [0.74-1.23],0.738976725069447
TAFA5,Chemokine-like protein TAFA-5,Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,15,0.76 [0.57-1.01],0.062613481106448
TAFA5,Chemokine-like protein TAFA-5,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,15,0.91 [0.77-1.08],0.270735316698604
TAFA5,Chemokine-like protein TAFA-5,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,Inverse variance weighted,15,1.02 [0.85-1.24],0.802428433444725
TAFA5,Chemokine-like protein TAFA-5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,Inverse variance weighted,15,1.01 [0.85-1.21],0.886087380460114
TAFA5,Chemokine-like protein TAFA-5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,Inverse variance weighted,15,0.97 [0.83-1.12],0.644639079512283
TAFA5,Chemokine-like protein TAFA-5,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,Inverse variance weighted,15,1.32 [0.97-1.79],0.0782705107313305
TAFA5,Chemokine-like protein TAFA-5,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,Inverse variance weighted,15,1.23 [0.58-2.62],0.584838489779151
TAFA5,Chemokine-like protein TAFA-5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,15,1.03 [0.96-1.10],0.391401934470685
TAFA5,Chemokine-like protein TAFA-5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,15,1.06 [0.85-1.32],0.585912731791538
TAFA5,Chemokine-like protein TAFA-5,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",Inverse variance weighted,15,0.94 [0.77-1.14],0.514012960908346
TAFA5,Chemokine-like protein TAFA-5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,Inverse variance weighted,15,0.97 [0.91-1.03],0.299713030178702
TAFA5,Chemokine-like protein TAFA-5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,Inverse variance weighted,15,1.00 [0.96-1.05],0.896807928429781
TAFA5,Chemokine-like protein TAFA-5,Chapter V Mental and behavioural disorders,Smoking dependency,Inverse variance weighted,15,1.18 [0.93-1.49],0.165300023901807
